NeuroLogica — a Samsung Electronics subsidiary — announced today that it received FDA 510(k) clearance for its next-gen BodyTom 64 scanner. Danvers, Massachusetts-based NeuroLogica designed its BodyTom 64 for point-of-care mobile computed tomography (CT). BodyTom 64 offers revisions to the company’s software and data acquisition system (DAS) based on customer feedback. For example, NeuroLogica incorporated […]
NeuroLogica Corp.
NeuroLogica wins CE mark for mobile CT systems
NeuroLogica announced today that its Elite mobile computed tomography (CT) systems received CE mark approval in Europe. The Samsung Electronics subsidiary received approval for its OmniTom Elite, BodyTom Elite and CereTom Elite mobile CT systems. “The achievement of this certification sheds light on our continued dedication to bringing innovative solutions to hospitals and clinics globally,” […]
FDA clears NeuroLogica’s OmniTom Elite with photon-counting detector technology
Samsung Electronics subsidiary NeuroLogica announced today that it received FDA 510(k) clearance for new technology on its OmniTom Elite. Danvers, Massachusetts–based NeuroLogica’s OmniTom Elite computed tomography (CT) scanner now has single-source photon-counting detector (PCD) technology, allowing it to generate spectral CT images at multiple energy levels. NeuroLogica said in a news release that its platform […]
Samsung’s NeuroLogica, MaxQ AI ink collab distro deal
Samsung Electronics (LON:BC94) subsidiary NeuroLogica said today that it inked a distribution deal with MaxQ AI to integrate its artificial intelligence software with NeuroLogica’s medical imaging tech in the U.S. and EU’s acute care marketplace. Through the deal, NeuroLogica said that it will offer MaxQ’s Accipio IX, part of the AI-company’s FDA-cleared and CE Mark approved […]
Samsung’s NeuroLogica wins $250m US DoD radiology supply contract
Samsung Electronics (LON:BC94) subsidiary NeuroLogica won a $250 million maximum firm-fixed-price contract to supply the US Dept. of Defense with radiology systems, accessories and training, according to a newly posted release. The contract for the Danvers, Mass.-based subsidiary is located in Massachusetts and has a five-year base and an additional five-year option period, according to the […]
Samsung win FDA 510(k) for digital radiography system
Samsung Electronics (LON:BC94) subsidiary NeuroLogica said yesterday it won FDA 510(k) clearance for its GC85A digital radiography system. The newly cleared ceiling x-ray unit comes with S-Vue imaging, a wireless S-Detector, mobile system control, smart stiching and other improvements, the company said. “The Samsung GC85A represents NeuroLogica’s latest commitment to introducing user and patient-centric innovation […]
NeuroLogica wins $12M DoD radiology contract extension
The U.S. Department of Defense awarded Danvers, Mass.-based device company NeuroLogica Corp. another year and a maximum of $12 million in a fixed-price radiological devices contract that may last as many as 7 years.
The Philadelphia, Pa.-based troop support division of the DoD contracted NeuroLogica for the 3rd extension of a contract that can be renewed a maximum of 4 more times.
Samsung puts more skin in medtech, nabs NeuroLogica in closed-doors deal
Technology titan Samsung Electronics (LON:BC94) made new moves in the medical device space with the stealthy buyout of Danvers, Mass.-based imaging devices maker NeuroLogica.
Johnson & Johnson hits 52-week high on boosted earnings forecast | Wall Street Beat
Shares of Johnson & Johnson (NYSE:JNJ) surged to a 52-week high today after the healthcare conglomerate boosted its 2012 earnings forecast after reporting a solid, Street-beating quarter (and despite a nearly 18% bottom-line slide).
Venture capital: Medical device “Big Exits” on the rise | Wall Street Beat
Venture-backed M&A activity in 2011 was higher than any other year since 2005, according to a new report tracking trends in lifesciences.
The medical device industry in 2011 had 18 "Big Exits," defined as venture-backed acquisitions where the up-front payment totaled $75 million or more.
